Author

S. Izreig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gariepy· 1 shared A. O. Donayo· 1 shared D. Avizonis· 1 shared G. Bridon· 1 shared K. S. Williams· 1 shared M. D. Minden· 1 shared M. N. Pollak· 1 shared M. S. Rudoltz· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gariepy

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivDec 20, 2019

Repression of LKB1 by miR-17~92 sensitizes MYC-dependent lymphoma to biguanide treatment

S. Izreig, A. Gariepy, A. O. Donayo…·R. G. Jones

The paper shows that miR-17~92 expression in Myc+ tumors increases sensitivity to biguanide treatment by disrupting bioenergetic stability in lymphoma cells.

DOI 10.1016/j.xcrm.2020.100014

humanproteomics

𝕏 PostBluesky